Cabaletta Bio, Inc. (CABA) — research page
US · us-cm-kg/NASDAQ/CABA · as of 2026-11-08
Identity and listing
The issuer is Cabaletta Bio, Inc., listed on NASDAQ under ticker CABA, ISIN US12674W1099; its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Delaware. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Cabaletta Bio, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CABA | source · 2026-11-08 |
| ISIN | US12674W1099 | source · 2026-10-08 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 66 filings across 31 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 5.5 days. The latest filing is dated 2026-11-06, two days before the record date, and is a regulatory filing. Exchange peers on NASDAQ (4,359 issuers) have a median cadence gap of 6.0 days, a median of 52 filings and a median latency of 5.0 days. Sector peers (176 issuers) have a median cadence gap of 5.5 days, a median of 65.5 filings and a median latency of 4.0 days. The issuer's filings by type are 24 regulatory filings, 19 directors' dealings, 10 results, 7 corporate news, 5 AGM/EGM and 1 prospectus.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 66 | 5.5 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-11-06 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-11-05 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-05 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
| 2026-10-30 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.
Orderability
The outcome is not determinable: the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 10 research houses: Cantor Fitzgerald, Citi, Evercore ISI, Guggenheim, H.C. Wainwright, Jefferies, Morgan Stanley, TD Cowen, Wells Fargo and William Blair.
| research house | analyst | source · read date |
|---|---|---|
| Cantor Fitzgerald | Josh Schimmer | issuer page · 2026-11-11 |
| Citi | Samantha Semenkow | issuer page · 2026-11-11 |
| Evercore ISI | Gavin Clark-Gartner | issuer page · 2026-11-11 |
| Guggenheim | Yatin Suneja | issuer page · 2026-11-11 |
| H.C. Wainwright | Douglas Tsao | issuer page · 2026-11-11 |
| Jefferies | Roger Song | issuer page · 2026-11-11 |
| Morgan Stanley | Michael Ulz | issuer page · 2026-11-11 |
| TD Cowen | Phil Nadeau | issuer page · 2026-11-11 |
| Wells Fargo | Derek Archila | issuer page · 2026-11-11 |
| William Blair | Matt Phipps | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001759138.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/CABA (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.cabalettabio.com/investors/analyst-coverage (coverage)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/CABA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US12674W1099"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:223e469c3bd73003.